Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease

Neurology

Volumn 55, Issue 11, 2000, Pages 1644-1649

  Wang, J C ^a   Kwon, J M ^a   Shah, P ^a   Morris, J C ^a   Goate, Alison ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; GENE PRODUCT;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR;

EID: 0034642230     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.11.1644     Document Type: Article

References (32)

1. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
2. Apolipoprotein E alleles as risk factors in Alzheimer's disease
3. Effect of ages, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analyses. APOE and Alzheimer's disease Meta Analysis Consortium
4. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
5. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease
6. Confirmation of the ε4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease
7. Apolipoprotein E ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region
8. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
9. Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals
10. Apolipoprotein E ε4 association with dementia in a population-based study: The Framingham Study
11. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
12. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene
13. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease
14. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene
15. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease
16. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
17. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: Independent risk and linkage disequilibrium with the known APOE polymorphism
18. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease
19. Absence of association between Alzheimer's disease and the -491 regulatory region polymorphism of APOE
20. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals
21. Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease
22. Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: Risk factors for Alzheimer's dementia?
23. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease
24. Validation of clinical diagnostic criteria for Alzheimer's disease
25. Cerebral amyloid deposition and diffuse plaques in 'normal' aging: Evidence for presymptomatic and very mild Alzheimer's disease
26. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease. Relationship of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype
27. 'Mini-mental state.' A practical method for grading the cognitive state of patients for clinicians
28. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
29. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease
30. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease
31. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
32. Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population